Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NKGen Biotech Inc. Common Stock
NKGN | US
0.06
USD0
0%
NKGN | US
Loading StockChartView...
About NKGen Biotech Inc. Common Stock
Sector
Industry
Earnings date
30/06/2024
As of date
24/04/2026
Close
0.06
Open
0.06
High
0.06
Low
0.06
View Less
NKGN | US
Risk
131.6
Sharpe
-0.07
Luna's Score
48/100
Recommendation
Hold
Luna says (NKGN | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
174.0%1 month
131.6%3 months
1131.9%6 months
776.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-0.40
Debt to assets
1.80
Ent. to EBITDA
-1.13
Ent. to rev.
964.78
PEG
-
Other Fundamentals
EBITDA
-30.23M
MarketCap
2.12M
MarketCap(USD)
2.12M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-
Short ratio
1.11
Short perc.
3.94
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.10
Range1M
0.10
Range3M
0.14
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.09
Price X volume
18.06
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.13 | - | - |
| Ent. to Revenue | 964.78 | - | - |
| PE Ratio | - | - | - |
| Price to Book | - | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 1,131.89 | - | - |
| Debt to Equity | -0.40 | - | - |
| Debt to Assets | 1.80 | - | - |
| Market Cap | 2.12M | - | - |
